Published in Immunology on August 01, 1972
An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med (1983) 1.45
The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum. Br J Exp Pathol (1973) 1.31
The migratory behavior of T blasts to contact sensitivity reactions in activelyand passively sensitized mice. Immunology (1975) 1.01
Lymphocyte chemotaxis in inflammation. IX. Further characterization of lymphocyte chemotactic lymphokines produced by purified protein derivative-stimulation in vitro and in vivo. Immunology (1984) 0.83
A comparison of the hematogenous cell infiltrate evoked by lymphokine injection with that of delayed hypersensitivity reactions. Am J Pathol (1978) 0.79
Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. Am J Physiol (1951) 10.63
Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med (1966) 3.57
Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J Exp Med (1955) 2.95
The site of leucocyte emigration during inflammation. Q J Exp Physiol Cogn Med Sci (1961) 2.69
The fine structure of the vascular response in hapten-specific delayed hypersensitivity and contact dermatitis. Lab Invest (1967) 2.50
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
An electron microscopic study of leukocyte emigration and vascular permeability in tuberculin sensitivity. Am J Pathol (1967) 1.53
A LYMPH-NODE PERMEABILITY FACTOR IN THE TUBERCULIN REACTION. J Pathol Bacteriol (1964) 1.45
Possible pharmacological mediators of delayed hypersensitivity. Br Med Bull (1967) 1.43
A quantitative method for the study of capillary permeability: extraction and determination of trypan blue in tissues. J Pathol Bacteriol (1962) 1.30
Studies on inflammation. Fate of intramural vascular deposits induced by histamine. Am J Pathol (1965) 1.14
[Usefulness and limitations of dye methods in the determination of increased permeability of the skin capillaires]. Med Exp Int J Exp Med (1962) 0.93
Early effects of beta irradiation on dermal vascular permeability to plasma proteins. Radiat Res (1966) 0.90
The use of I-131-albumin in assays of drugs that increase vascular permeability in the skin of guinea pigs. Aust J Exp Biol Med Sci (1965) 0.89
[Studies on hypersensitivity. V. Analysis of various types of hypersensitivity induced by the injection of an immune complex in complete adjuvants]. Ann Inst Pasteur (Paris) (1966) 0.89
[Studies on hypersensitivity. I. Demonstration and description of an increase of vascular permeability in the tuberculin hypersensitivity reactions]. Ann Inst Pasteur (Paris) (1963) 0.86
[Studies on hypersensitivity VII. A quantitative study of the laws governing the increase of vascular permeability in the Arthus reaction in the guinea pig]. Rev Fr Etud Clin Biol (1967) 0.85
The hemostatic mechanism and its defects. Int Rev Exp Pathol (1968) 0.81
[Permeability changes caused by animal venoms]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1955) 0.80
Use of radioactiv isotopes for continuous recording of increased vascular permeability in the rabbit ear. J Physiol (1970) 0.80
Allergic inflammation. I. Simultaneous measurement of vascular permeability to isotope-labelled cells and protein in immediate and delayed hypersensitivity. Bibl Anat (1969) 0.79
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (1981) 6.36
Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (1973) 6.34
Calcitonin gene-related peptide is a potent vasodilator. Nature (1985) 6.13
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med (1994) 4.36
Role of prostaglandin-mediated vasodilatation in inflammation. Nature (1977) 3.95
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing. Lancet (1991) 3.60
Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol (1979) 3.58
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol (2000) 3.05
Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med (1995) 2.83
Lung volume reduction surgery for emphysema. Med J Aust (1997) 2.70
Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature (1988) 2.54
Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screen (1994) 2.45
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol (1985) 2.38
Carcinoma of the Stomach. Br Med J (1937) 2.34
Two methods for assessing the risk-factor composition of the HIV-1 epidemic in heterosexual women: southeast England, 1988-1991. AIDS (1992) 2.32
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
Vasodilatation in the submaxillary gland of the cat. J Physiol (1965) 2.12
Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a. J Exp Med (1981) 2.12
Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun (1985) 2.07
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Evidence that neutrophil accumulation induced by interleukin-1 requires both local protein biosynthesis and neutrophil CD18 antigen expression in vivo. Br J Pharmacol (1988) 1.90
Visceral Pain. Br Med J (1937) 1.89
The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun (1993) 1.88
A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol (2000) 1.84
The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J (2009) 1.81
Evaluation of factors affecting the membrane filter technique for testing drinking water. Appl Environ Microbiol (1982) 1.80
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol (1986) 1.68
Proceedings: Role of prostaglandins in reactions of cellular immunity. Br J Pharmacol (1974) 1.67
LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin. Am J Respir Cell Mol Biol (2001) 1.64
Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today (2000) 1.62
Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol (1993) 1.62
Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J Exp Med (1996) 1.58
Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay. J Exp Med (1983) 1.56
Cyclooxygenase-2: regulation and relevance in inflammation. Biochem Pharmacol (1995) 1.56
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J (2003) 1.55
Viral gastroenteritis aboard a cruise ship. Lancet (1989) 1.53
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Br J Pharmacol (1983) 1.53
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med (1993) 1.53
Prostaglandins and lymphokines in arthritis. Prostaglandins (1974) 1.52
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
The platelet in asthma. Lancet (1984) 1.50
Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg (1999) 1.50
Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood (1998) 1.49
Calicivirus associated with winter vomiting disease. Lancet (1978) 1.49
Identification and characterization of mouse small intestine mucosal receptors for Escherichia coli K-12(K88ab). Infect Immun (1986) 1.47
The MES-1 murine enhancer element is closely associated with the heterogeneous 5' ends of two divergent transcription units. Mol Cell Biol (1986) 1.47
Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma (2003) 1.46
Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature (1988) 1.46
Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet (1982) 1.45
Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol (1990) 1.45
Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol (1990) 1.45
Platelet-activating factor: a possible mediator of the dual response to allergen? Clin Allergy (1984) 1.45
Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype. J Clin Microbiol (2001) 1.44
Prostacyclin (PGI2) potentiates bradykinin-induced plasma exudation in rabbit skin [proceedings]. Br J Pharmacol (1978) 1.44
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Interactions between the tachykinins and calcitonin gene-related peptide lead to the modulation of oedema formation and blood flow in rat skin. Br J Pharmacol (1989) 1.43
Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun (1994) 1.43
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Imaging the Fano lattice to 'hidden order' transition in URu(2)Si(2). Nature (2010) 1.42
Endothelin induces potent microvascular constriction. Br J Pharmacol (1988) 1.42
An assessment of the ability of a silver-releasing device to prevent bacterial contamination of urethral catheter drainage systems. Br J Urol (1996) 1.40
The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins (1981) 1.40
Current status of genitourinary fistula. Obstet Gynecol (1988) 1.40
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Chemical mediators of vascular responses in inflammation: a two mediator hypothesis [proceedings]. Br J Pharmacol (1977) 1.39
Primary pulmonary hypertension: new reasons for optimism? Med J Aust (1998) 1.39
Alpha 1-adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol Sci (1994) 1.38
Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann Rheum Dis (1990) 1.38
Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol (1999) 1.38
Antiasthma drugs and airway hyperreactivity. Am Rev Respir Dis (1992) 1.38
Proceedings:Simultaneous measurement of local plasma exudation and blood flow changes induced by intradermal injection of vasoactive substances, using [131I]albumen and 133Xe. J Physiol (1976) 1.38
The immunotherapy of acute myelogenous leukaemia using intravenous BCG. Br J Haematol (1977) 1.35
Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br J Pharmacol (1982) 1.35
An in vivo model for studying platelet aggregation and disaggregation. Thromb Haemost (1982) 1.33
Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir Res (2001) 1.31
Endometriosis in 1,000 consecutive celiotomies: incidence and management. Am J Obstet Gynecol (1977) 1.30
An evaluation of cusum analysis in asthma. Br J Dis Chest (1980) 1.29